BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pasarín M, Abraldes JG, Liguori E, Kok B, La Mura V. Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction. World J Gastroenterol 2017; 23(37): 6777-6787 [PMID: 29085222 DOI: 10.3748/wjg.v23.i37.6777]
URL: https://www.wjgnet.com/1007-9327/full/v23/i37/6777.htm
Number Citing Articles
1
A A Shipovskaya, O P Dudanova, I V Kurbatova. The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver diseaseTerapevticheskii arkhiv 2018; 90(8): 63 doi: 10.26442/terarkh201890863-68
2
Taraneh Faghihi Langroudi, Habib Haybar, Saeed Alipour Parsa, Mohamad Mahjoorian, Isa Khaheshi, Mohammadreza Naderian. The severity of coronary artery disease was not associated with non-alcoholic fatty liver disease in a series of 264 non-diabetic patients who underwent coronary angiographyRomanian Journal of Internal Medicine 2018; 56(3): 167 doi: 10.2478/rjim-2018-0009
3
Manna Li, Ming Qian, Kathy Kyler, Jian Xu. Adipose Tissue-Endothelial Cell Interactions in Obesity-Induced Endothelial DysfunctionFrontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.681581
4
Mario Masarone, Valerio Rosato, Marcello Dallio, Antonietta Gerarda Gravina, Andrea Aglitti, Carmelina Loguercio, Alessandro Federico, Marcello Persico. Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver DiseaseOxidative Medicine and Cellular Longevity 2018; 2018: 1 doi: 10.1155/2018/9547613
5
Yan Lv, Nishant Patel, Hai-Jun Zhang. The progress of non-alcoholic fatty liver disease as the risk of liver metastasis in colorectal cancerExpert Review of Gastroenterology & Hepatology 2019; 13(12): 1169 doi: 10.1080/17474124.2019.1697231
6
Agostino Di Ciaula, Federico Carbone, Harshitha Shanmugham, Emilio Molina-Molina, Leonilde Bonfrate, Stefano Ministrini, Fabrizio Montecucco, Piero Portincasa. Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liverEuropean Journal of Internal Medicine 2021; 89: 56 doi: 10.1016/j.ejim.2021.03.036
7
Adel Hammoutene, Pierre-Emmanuel Rautou. Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver diseaseJournal of Hepatology 2019; 70(6): 1278 doi: 10.1016/j.jhep.2019.02.012
8
Emilio Molina-Molina, Harshitha Shanmugam, Agostino Di Ciaula, Ignazio Grattagliano, Domenica Maria Di Palo, Vincenzo O. Palmieri, Piero Portincasa. (13C)-Methacetin breath test provides evidence of subclinical liver dysfunction linked to fat storage but not lifestyleJHEP Reports 2021; 3(1): 100203 doi: 10.1016/j.jhepr.2020.100203
9
Miren Bravo, Imma Raurell, Diana Hide, Anabel Fernández-Iglesias, Mar Gil, Aurora Barberá, Maria Teresa Salcedo, Salvador Augustin, Joan Genescà, María Martell. Restoration of liver sinusoidal cell phenotypes by statins improves portal hypertension and histology in rats with NASHScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-56366-2
10
Luz M. Medrano, Pilar Garcia-Broncano, Juan Berenguer, Juan González-García, Ma Ángeles Jiménez-Sousa, Josep M. Guardiola, Manuel Crespo, Carmen Quereda, José Sanz, Isabel Canorea, Ana Carrero, Victor Hontañón, Ma Ángeles Muñoz-Fernández, Salvador Resino. Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patientsAIDS 2018; 32(9): 1095 doi: 10.1097/QAD.0000000000001787
11
Xue-Kai Wang, Zong-Gen Peng. Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver DiseaseFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.655557
12
Murali Ganesan, Larisa Y Poluektova, Kusum K Kharbanda, Natalia A Osna. Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progressionWorld Journal of Gastroenterology 2019; 25(4): 398-410 doi: 10.3748/wjg.v25.i4.398
13
Niklas Verloh, Ingo Einspieler, Kirsten Utpatel, Karin Menhart, Stefan Brunner, Frank Hofheinz, Jörg van den Hoff, Philipp Wiggermann, Matthias Evert, Christian Stroszczynski, Dirk Hellwig, Jirka Grosse. In vivo confirmation of altered hepatic glucose metabolism in patients with liver fibrosis/cirrhosis by 18F-FDG PET/CTEJNMMI Research 2018; 8(1) doi: 10.1186/s13550-018-0452-y